Compounds > ondansetron

ondansetron and pergolide

ondansetron has been researched along with pergolide in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Sen, S; Sinha, N1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, Q; Davidson, C; Ellinwood, EH; Lee, TH; Mi, J; Wetsel, WC; Xiong, X; Zhang, X1
Davidson, C; Ellinwood, EH; Lazarus, C; Lee, TH; Wetsel, WC; Zhang, X1
Chen, Q; Davidson, C; Ellinwood, EH; Lee, TH; Liu, Y; Sun, QA; Wetsel, WC; Xiong, X; Zhang, X1
Ahn, C; Chen, Q; Davidson, C; Ellinwood, EH; Gopalan, R; Lee, TH; Mannelli, P; Patkar, AA; Weese, GD1
Bhatia, KS; Fowler, JC; Lee, TH; Szabo, ST; Wetsel, WC1

Reviews

1 review(s) available for ondansetron and pergolide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for ondansetron and pergolide

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity.
    Biochemical and biophysical research communications, 2006, Feb-24, Volume: 340, Issue:4

    Topics: Animals; Behavior, Animal; Brain; Cocaine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance; Locomotion; Male; Ondansetron; Pergolide; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Serotonin Antagonists

2006
Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:2

    Topics: Animals; Behavior, Addictive; Brain; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Glutamic Acid; Male; Neurons; Nucleus Accumbens; Ondansetron; Pergolide; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Serotonin Antagonists; Synaptic Transmission

2007
Reversal of cocaine sensitization-induced behavioral sensitization normalizes GAD67 and GABAA receptor alpha2 subunit expression, and PKC zeta activity.
    Biochemical and biophysical research communications, 2007, May-11, Volume: 356, Issue:3

    Topics: Animals; Behavior, Animal; Caudate Nucleus; Cocaine; Glutamate Decarboxylase; Isoenzymes; Male; Nucleus Accumbens; Ondansetron; Pergolide; Prefrontal Cortex; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Stereotyped Behavior

2007
Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal.
    European journal of pharmacology, 2007, Jun-22, Volume: 565, Issue:1-3

    Topics: Animals; Drug Therapy, Combination; Male; Methamphetamine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley; Self Administration; Substance Withdrawal Syndrome

2007
Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.
    Behavioural brain research, 2011, Sep-30, Volume: 223, Issue:1

    Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Infusion Pumps, Implantable; Ketanserin; Male; Methamphetamine; Mianserin; Mirtazapine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley

2011